December 11, 2024 | 3 PM - 5 PM | LabCentral
December 11, 2024
3 PM - 5 PM | LabCentral
WHAT TO EXPECT:
LabCentral is honored and excited to host a live taping of our founder-based video series, The Dish! Join us for a very special episode featuring acclaimed geneticist and multi-biotech-startup guru, George Church!
Widely known for discovering the first direct genomic sequencing method, George Church is reshaping the future of genetics. A professor at Harvard and MIT and a founding professor at the Wyss Institute, Professor Church has co-founded over 50 startups—15+ of which have resided at LabCentral. Named one of Time’s 100 Most Influential People in the World in 2017, Church continues to make headlines with his de-extinction work at Colossal Biosciences, aiming to bring back species like the woolly mammoth. We’re thrilled to Dish with this biotech industry visionary and hope you can join the conversation!
The program is expected to run approximately 45 minutes, with additional time at the end for questions from attendees.
Space is limited, so please RSVP for your opportunity to join us live in the audience. Be sure to submit your questions for George ahead of time during registration! Are you ready to Dish?
WHAT TO EXPECT:
LabCentral is honored and excited to host a live taping of our founder-based video series, The Dish! Join us for a very special episode featuring acclaimed geneticist and multi-biotech-startup guru, George Church!
Widely known for discovering the first direct genomic sequencing method, George Church is reshaping the future of genetics. A professor at Harvard and MIT and a founding professor at the Wyss Institute, Professor Church has co-founded over 50 startups—15+ of which have resided at LabCentral. Named one of Time’s 100 Most Influential People in the World in 2017, Church continues to make headlines with his de-extinction work at Colossal Biosciences, aiming to bring back species like the woolly mammoth. We’re thrilled to Dish with this biotech industry visionary and hope you can join the conversation!
The program is expected to run approximately 45 minutes, with additional time at the end for questions from attendees.
Space is limited so please RSVP for your opportunity to join us live in the audience. Be sure to submit your questions for George ahead of time during registration! Are you ready to Dish?
AGENDA:
3:00 PM
3:30 PM
4:15 PM
4:30 PM
5:00 PM
3:00 PM - Arrival & Registration
3:30 PM - Program Begins
4:15 PM - Q&A
4:30 PM - Networking
5:00 PM - Event Close
3:00 PM
3:30 PM
4:15 PM
4:30 PM
5:00 PM
Arrival & Registration
Program Begins - Live conversation with Johannes Fruehauf & George Church
Q&A
Networking
Event Close
Arrival & Registration
Program Begins - Live conversation
with Johannes Fruehauf & George Church
Q&A
Networking
Event Close
ABOUT OUR SPEAKERS:
ABOUT OUR SPEAKERS:
George Church
Harvard Medical School & MIT
George Church is widely recognized for his innovative contributions to genomic science and his many pioneering contributions to chemistry and biomedicine. In 1984, he developed the first direct genomic sequencing method, which resulted in the first genome sequence (the human pathogen, H. pylori). He helped initiate the Human Genome Project in 1984 and the Personal Genome Project in 2005. George invented the broadly applied concepts of molecular multiplexing and tags, homologous recombination methods, and array DNA synthesizers. His many innovations have been the basis for a number of companies including Editas (Gene therapy); Gen9bio (Synthetic DNA); and Veritas Genetics (full human genome sequencing).
George is Professor of Genetics at Harvard Medical School and Professor of Health Sciences and Technology at Harvard and the Massachusetts Institute of Technology (MIT). He is Director of the U.S. Department of Energy Technology Center and Director of the National Institutes of Health Center of Excellence in Genomic Science. He has received numerous awards including the 2011 Bower Award and Prize for Achievement in Science from the Franklin Institute and election to the National Academy of Sciences and Engineering.
George Church is widely recognized for his innovative contributions to genomic science and his many pioneering contributions to chemistry and biomedicine. In 1984, he developed the first direct genomic sequencing method, which resulted in the first genome sequence (the human pathogen, H. pylori). He helped initiate the Human Genome Project in 1984 and the Personal Genome Project in 2005. George invented the broadly applied concepts of molecular multiplexing and tags, homologous recombination methods, and array DNA synthesizers. His many innovations have been the basis for a number of companies including Editas (Gene therapy); Gen9bio (Synthetic DNA); and Veritas Genetics (full human genome sequencing).
George is Professor of Genetics at Harvard Medical School and Professor of Health Sciences and Technology at Harvard and the Massachusetts Institute of Technology (MIT). He is Director of the U.S. Department of Energy Technology Center and Director of the National Institutes of Health Center of Excellence in Genomic Science. He has received numerous awards including the 2011 Bower Award and Prize for Achievement in Science from the Franklin Institute and election to the National Academy of Sciences and Engineering.
Johannes Fruehauf
LabCentral, BioLabs, & Mission BioCapital
Johannes Fruehauf (MD, PhD) is the Founder and President of LabCentral, the preeminent private/public partnership model for life science incubator space, while also serving as CEO for BioLabs, the largest provider of laboratory co-working space for startups nationwide. He is also the founder and General Partner of Mission BioCapital (MBC). In his role at MBC, he sources, diligences, and leads new life-science investment transactions and represents the fund on the board of a number of MBC portfolio companies.
Dr. Fruehauf has a background as a physician working in diverse health systems. In his 15+ years as a serial biotech entrepreneur, Dr. Fruehauf has dedicated much of his professional endeavors to the mission of re-defining life science entrepreneurship and building start-up ecosystems. Dr. Fruehauf studied medicine in Germany and France, while also conducting field work in Africa (Zimbabwe and Guinea). He graduated from University of Frankfurt and received his doctorate from the University of Heidelberg. Johannes is the author of over 30 peer reviewed publications and is named inventor on 9 patents.
Johannes Fruehauf (MD, PhD) is the Founder and President of LabCentral, the preeminent private/public partnership model for life science incubator space, while also serving as CEO for BioLabs, the largest provider of laboratory co-working space for startups nationwide. He is also the founder and General Partner of Mission BioCapital (MBC). In his role at MBC, he sources, diligences, and leads new life-science investment transactions and represents the fund on the board of a number of MBC portfolio companies.
Dr. Fruehauf has a background as a physician working in diverse health systems. In his 15+ years as a serial biotech entrepreneur, Dr. Fruehauf has dedicated much of his professional endeavors to the mission of re-defining life science entrepreneurship and building start-up ecosystems. Dr. Fruehauf studied medicine in Germany and France, while also conducting field work in Africa (Zimbabwe and Guinea). He graduated from University of Frankfurt and received his doctorate from the University of Heidelberg. Johannes is the author of over 30 peer reviewed publications and is named inventor on 9 patents.
READY TO DISH?
READY TO DISH?